Here is how Cencora (COR) and Intensity Therapeutics Inc. (INTS) have performed compared to their sector so far this year.
Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here, we discuss three medical device stocks ,COR, HIMS and PBH, that offer cheap valuations, making them attractive bets amid tariff risks.
![]() ABG 8 months ago | Other | €0.51 Per Share |
![]() ABG 11 months ago | Other | €0.51 Per Share |
![]() ABG 8 Feb 2024 | Other | €0.51 Per Share |
![]() ABG 9 Nov 2023 | Other | €0.51 Per Share |
![]() ABG 10 Aug 2023 | Other | €0.48 Per Share |
29 Apr 2025 29 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
31 Jul 2024 Date | | - Cons. EPS | - EPS |
1 May 2024 Date | | - Cons. EPS | - EPS |
![]() ABG 8 months ago | Other | €0.51 Per Share |
![]() ABG 11 months ago | Other | €0.51 Per Share |
![]() ABG 8 Feb 2024 | Other | €0.51 Per Share |
![]() ABG 9 Nov 2023 | Other | €0.51 Per Share |
![]() ABG 10 Aug 2023 | Other | €0.48 Per Share |
29 Apr 2025 29 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
31 Oct 2024 Date | | - Cons. EPS | - EPS |
31 Jul 2024 Date | | - Cons. EPS | - EPS |
1 May 2024 Date | | - Cons. EPS | - EPS |
Medical Distribution Industry | Healthcare Sector | Dr. Robert P. Mauch Ph.D., PharmD CEO | XFRA Exchange | US03073E1055 ISIN |
United States Country | 46,000 Employees | 14 Feb 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
U.S. Healthcare Solutions:
International Healthcare Solutions: